| SPRB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SPRB market cap history going back to 10/9/2020:
Also see: SPRB Shares Outstanding History and SPRB YTD Return |
SPRB Market Cap History — Spruce Biosciences Capitalization Over Time
As of 5/11/2026 Spruce Biosciences has a market cap of 155.23 million. Investors often follow the SPRB market cap history to compare the size of the company over time.
This page shows SPRB market capitalization trends over time, with 24 market cap datapoints presented, dating back to 10/9/2020.
| SPRB Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
SPRB Historical Market Cap: -14.04% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| SPRB Stock Price Chart |
| About Spruce Biosciences Inc |
| Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with significant unmet medical needs. Co. is initially developing its wholly owned product candidate, Tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). It is also developing Tildacerfont for females suffering from polycystic ovary syndrome (PCOS). It has initiated CAHmelia-203, a placebo-controlled, double-blind Phase IIb clinical trial in adult patients with classic CAH with elevated levels of androstenedione (A4) at baseline. We show 24 historical shares outstanding datapoints in our SPRB shares outstanding history coverage, used to compute SPRB market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SPRB market cap history over the course of time is important for investors interested in comparing SPRB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SPRB versus a peer is one thing; comparing SPRB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SPRB can fluctuate over the course of history. With this page we aim to empower investors researching SPRB by allowing them to research the SPRB market cap history. |
| SPRB Current Stock Quote |
Quotes delayed 20 minutes  Free SPRB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SPRB Share Performance |
| Market Cap Peers |
| Spruce Biosciences (SPRB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SPRO Market Cap History SPRY Market Cap History SQL Market Cap History SQZ Market Cap History SRDX Market Cap History SRGA Market Cap History SRNE Market Cap History SRPT Market Cap History SRRA Market Cap History SRRK Market Cap History More Healthcare companies » |
SPRB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
